ATARA BIOTHERAPEUTICS, INC. Unrecognized Tax Benefits, Period Increase (Decrease)
ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Unrecognized Tax Benefits, Period Increase (Decrease) of $800.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease · last filed 2018-02-27
- ATARA BIOTHERAPEUTICS, INC. unrecognized tax benefits, period increase (decrease) for the quarter ending 2016-09-30 was $300.00K.
- ATARA BIOTHERAPEUTICS, INC. unrecognized tax benefits, period increase (decrease) for fiscal 2017 was $800.00K, a 100.00% increase from fiscal 2016.
- ATARA BIOTHERAPEUTICS, INC. unrecognized tax benefits, period increase (decrease) for fiscal 2016 was $400.00K.
| Period end | Unrecognized Tax Benefits, Period Increase (Decrease) 3 month | Unrecognized Tax Benefits, Period Increase (Decrease) 12 month | Unrecognized Tax Benefits, Period Increase (Decrease) 12 month as first filed |
|---|---|---|---|
| 2017-12-31 | $800.00K 10-K · filed 2018-02-27 | ||
| 2016-12-31 | $400.00K 10-K · filed 2018-02-27 | $600.00K 10-K · filed 2017-03-09 | |
| 2016-09-30 | $300.00K 10-Q · filed 2016-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |